Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 12—December 2019
Dispatch

Cat-to-Human Transmission of Mycobacterium bovis, United Kingdom

Catherine M. O’ConnorComments to Author , Muhammad Abid1, Amanda L. Walsh, Behrooz Behbod2, Tony Roberts, Linda V. Booth, H. Lucy Thomas, Noel H. Smith, Eleftheria Palkopoulou, James Dale, Javier Nunez-Garcia3, and Dilys Morgan
Author affiliations: Public Health England, London, UK (C.M. O’Connor, A.L. Walsh, H.L. Thomas, D. Morgan); Public Health England, Chilton, UK (M. Abid, B. Behbod); Animal and Plant Health Agency, Oxford, UK (T. Roberts); Public Health England, Fareham, UK (L.V. Booth); Animal and Plant Health Agency, Weybridge, UK (N.H. Smith, E. Palkopoulou, J. Dale, J. Nunez-Garcia)

Cite This Article

Abstract

Human infection with Mycobacterium bovis is reported infrequently in the United Kingdom. Most cases involve previous consumption of unpasteurized milk. We report a rare occurrence of 2 incidents of cat-to-human transmission of M. bovis during a cluster of infection in cats.

In the United Kingdom, Mycobacterium bovis infection in humans is relatively rare (1), and most cases involve previous exposure to well-recognized risk factors, such as unpasteurized milk (2). However, with >4,500 new cases reported in cattle herds each year during 2014–2018 (3), M. bovis remains a major issue for animal health in large parts of England and Wales.

Cats are considered spillover hosts of M. bovis in the United Kingdom. During 2002–2010, <30 feline cases of M. bovis infection were confirmed by laboratory culture each year by the Animal and Plant Health Agency M. bovis Reference Laboratory (4). Cases of M. bovis infection in cats are generally restricted to areas to which bovine tuberculosis (TB) is endemic (5), where infected cattle and wildlife have the potential to introduce M. bovis into cat populations. Most reported feline cases of M. bovis infection in the United Kingdom are sporadic, and outside the occasional household-linked cases, spatially or temporally linked clusters are unusual.

The potential for cat-to-human transmission of M. bovis has always been recognized. Although concurrent infection in cats and humans in the same household has been reported (6), and reports of potential transmission exist (7), documented transmission events have not been clearly described. We report a rare occurrence of microbiologically and genetically confirmed cat-to-human transmission of M. bovis.

The Study

During December 2012–March 2013, a veterinary practice in Berkshire, England, diagnosed 7 confirmed (culture from lesions or wounds) and 2 suspected (clinically compatible) cases of M. bovis disease in domestic cats. One additional suspected case was identified after an interview with an affected household. No samples were available from any of the suspected cases for confirmation for this study. The 10 cats belonged to 9 separate households, of which 6 were <250 m from each other. All cats had severe systemic infection, including discharging lymph nodes, nonhealing or discharging infected wounds, and radiographic pulmonary signs. Isolates from the culture-confirmed cases were of the same genotype (10:u), were similar by whole-genome sequencing, and separated into 2 clusters by a single informative polymorphism (8). Veterinary investigations did not determine the source of infection, but the source was believed to be infected wildlife, most likely rodents or badgers, for at least some of the cats. Further information on the investigation into this cluster of infection in cats has been reported (8).

The unusual size and severity of the cluster of feline M. bovis cases led to the decision that TB screening (9) would be offered to all human household members and others who had close contact with the infected cats. Local Health Protection Teams of Public Health England identified 39 human contacts; 24 accepted TB screening. Three persons (person A, 13 years of age; person B, 18 years of age; and person C, 39 years of age) were positive for latent TB infection (LTBI) by a combination of interferon-γ release assays and Mantoux screening tests; none showed evidence of active disease.

These 3 persons with LTBI reported close contact with 2 cats with culture-confirmed M. bovis infection while the cats had clinical disease (1 had a discharging nonhealing wound and 1 had a discharging lymph node). Apart from contact with the infected cats, no other risk factors for M. bovis or M. tuberculosis exposure were identified. Because it was not possible to isolate the causative organism from cats or persons with LTBI or identify the likely exposure or source of infection, it was not possible to determine whether transmission of M. bovis from these affected cats to their human contacts had occurred. All 3 persons with LTBI were offered chemoprophylaxis, but only 1 (person A) accepted. All 3 persons were advised to go to local health services if any symptoms potentially indicative of active TB developed.

Six months after initial screening, person B was medically assessed because of nonspecific abdominal pain. Chest radiographs showed evidence of pathologic changes potentially indicative of TB. M. bovis was isolated from pleural biopsy samples. Shortly after person B had clinical illness, a nonhousehold human contact (person D, 20 years of age) of person B and their cat also had M. bovis isolated from pleural biopsy samples after reporting chest pain and fever. Person D had initially declined screening. Persons B and D had close contact with the infected cat while it was systemically ill (including a discharging wound). The cat died before M. bovis infection was diagnosed. Both persons completed a 9-month course of rifampin, isoniazid, pyrazinamide, and ethambutol and responded well to treatment (10).

Figure

Thumbnail of Whole-genome sequencing phylogenetic relationship of genotype 10:u isolates of Mycobacterium bovis from 1 human, 7 cats, 11 cattle, and 1 alpaca, and 10:a isolates from 3 cattle (maximum-likelihood tree of all single-nucleotide polymorphisms [SNPs]). Cat and human isolates are indicated by solid arrowheads. Heat-killed cultures were sequenced by using a MiSeq Sequencer (Illumina, https://www.illumina.com), and reads were mapped by using reference strain AF2122. The average coverage

Figure. Whole-genome sequencing phylogenetic relationship of genotype 10:u isolates of Mycobacterium bovis from 1 human, 7 cats, 11 cattle, and 1 alpaca, and 10:a isolates from 3 cattle (maximum-likelihood tree of all...

Molecular analysis showed that persons B and D, who had active M. bovis disease, and the cat all had M. bovis isolates of the same genotype. Whole-genome sequencing of samples from one of the humans and the cat showed that their isolates were indistinguishable (Figure). (Sequencing was not possible for the isolate from the second human patient.) This evidence, coupled with the timeline of onset of disease in the cat (March 2013) and its human contacts (October 2013), and the lack of any other risk factors for exposure to M. bovis, indicated that the cat was the likely source of infection for these 2 affected persons.

Conclusions

Before this incident, the absence of confirmed reports of human cases of M. bovis infection acquired from pet cats led us to believe that the risk for cat-to-human transmission was negligible. Thus, no public health action was warranted. However, with the evidence of transmission from 1 cat to these 2 patients, the risk for spread of M. bovis from cats to their human contacts was increased from negligible to low (11). Cats with clinical signs compatible with disseminated disease are believed to have the greatest risk to humans, most likely by ingestion from a contaminated environment, following handling of discharges from exudative tuberculous lesions, or by aerosols from cats with respiratory signs or aerosol-generating procedures.

Public Health England now advises that all close contacts of household companion animals with confirmed M. bovis infections should be assessed by a public health professional and receive guidance on how to best minimize zoonotic transmission (12,13). In addition, as part of an enhanced surveillance system in England and Wales, newly diagnosed human case-patients with M. bovis infection are now also asked explicitly about contact with pets with suspected or confirmed M. bovis disease (14).

In summary, M. bovis disease in companion animals, particularly cats with severe systemic features including exudative lesions, can no longer be regarded as posing a negligible public health risk. Guidance should be provided to minimize the risk for transmission to human contacts.

Ms. O’Connor is an epidemiologist in the National Infection Service at Public Health England, London, UK. Her primary research interests are epidemic intelligence, risk assessment, and emerging zoonotic infections.

Top

Acknowledgment

We thank Kate McPhedran for assistance at the time of the incidents and Karen Gover and Monika Klita for assistance in testing and analyzing human and animal isolates.

Top

References

  1. Public Health England. Tuberculosis caused by Mycobacterium bovis (M. bovis): notification data; 2018 [cited 2018 Nov 13]. https://www.gov.uk/government/publications/mycobacterium-bovis-mbovis-tuberculosis-annual-data
  2. Davidson  JA, Loutet  MG, O’Connor  C, Kearns  C, Smith  RM, Lalor  MK, et al. Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014. Emerg Infect Dis. 2017;23:37786. DOIPubMed
  3. Department for Environment, Food, and Rural Affairs. Tuberculosis (TB) in cattle in Great Britain (update 17 October 2018); 2018 [cited 2018 Nov 13]. https://www.gov.uk/government/statistical-data-sets/tuberculosis-tb-in-cattle-in-great-britain
  4. Department for Environment, Food, and Rural Affairs. Incidents of M. bovis infection in non-bovine domestic animals and wild deer in GB confirmed by laboratory culture; 2015 [cited 2018 Dec 3]. www.gov.uk/government/uploads/system/uploads/attachment_data/file/232602/bovinetb-otherspecies-27aug13.xls
  5. Gunn-Moore  DA, McFarland  SE, Brewer  JI, Crawshaw  TR, Clifton-Hadley  RS, Kovalik  M, et al. Mycobacterial disease in cats in Great Britain: I. Culture results, geographical distribution and clinical presentation of 339 cases. J Feline Med Surg. 2011;13:93444. DOIPubMed
  6. Ramdas  KE, Lyashchenko  KP, Greenwald  R, Robbe-Austerman  S, McManis  C, Waters  WR. Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012. Emerg Infect Dis. 2015;21:4803. DOIPubMed
  7. Lewis-Jonsson  J. Transmission of tuberculosis from cats to human beings. Acta Tuberc Pneumol Scand. 1946;20:102.
  8. Roberts  T, O’Connor  C, Nuñez-Garcia  J, de la Rua-Domenech  R, Smith  NH. Unusual cluster of Mycobacterium bovis infection in cats. Vet Rec. 2014;174:326. DOIPubMed
  9. Public Health England. Tuberculosis screening; 2018 [cited 2019 Jul 30]. https://www.gov.uk/guidance/tuberculosis-screening
  10. Talwar  A, McGown  A, Langham  T, Abid  M, Pilling  J; Department of Respiratory Medicine, Royal Berkshire Hospital. A very strange tail. Thorax. 2014;69:115960. DOIPubMed
  11. Human Animal Infections and Risk Surveillance group (HAIRS). Qualitative assessment of the risk that cats infected with Mycobacterium bovis present to human health; 2014 [cited 2018 Dec 3]. https://www.gov.uk/government/publications/hairs-risk-assessment-mycobacterium-bovis-in-cats
  12. Public Health England. Bovine tuberculosis: guidance on management of the public health consequences of tuberculosis in cattle and other animals (England); 2014 [cited 2018 Dec 3]. https://www.gov.uk/government/publications/bovine-tuberculosis-tb-public-health-management
  13. UK Government. Bovine tuberculosis in domestic pets; 2014 [cited 2019 Jul 30]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/596240/AG-TBYP-01e.pdf
  14. Public Health England. Mycobacterium bovis (M. bovis): enhanced surveillance questionnaire; 2016 [cited 2018 Dec 3]. https://www.gov.uk/government/publications/mycobacterium-bovis-m-bovis-enhanced-surveillance-questionnaire

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2512.190012

Original Publication Date: 10/31/2019

1Current affiliation: United Arab Emirates University, Al Ain, United Arab Emirates.

2Current affiliations: Communicable Disease Surveillance Centre, Public Health Wales, Cardiff, Wales, UK, and Cardiff University, Cardiff.

3Current affiliation: Genomics Medicine Ireland, Dublin, Ireland.

Table of Contents – Volume 25, Number 12—December 2019

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Catherine M. O’Connor, TARGET, Emerging Infections and Zoonoses Team, National Infection Service, Public Health England, 61 Colindale Ave, London NW9 5EQ, UK

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: November 18, 2019
Page updated: November 18, 2019
Page reviewed: November 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external